OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Operating Profit History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹-15 Cr | ₹-9.81 Cr | ₹-9.70 Cr | ₹-7.12 Cr | ₹1.48 Cr |
What is the latest Operating Profit of OXYGENTA PHARMACEUTICAL ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹-15 Cr |
| Mar2025 | ₹-9.81 Cr |
| Mar2024 | ₹-9.70 Cr |
| Mar2023 | ₹-7.12 Cr |
| Mar2022 | ₹1.48 Cr |
How is Operating Profit of OXYGENTA PHARMACEUTICAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-15 Cr | Negative | |
| Mar2025 | ₹-9.81 Cr | Negative | |
| Mar2024 | ₹-9.70 Cr | Negative | |
| Mar2023 | ₹-7.12 Cr | Negative | |
| Mar2022 | ₹1.48 Cr | - | |
Compare Operating Profit of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹223.3 Cr | -5.5% | 18.4% | -29.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -5.5% |
18.4% |
-29.1% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses